FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jon Stoessl

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Living Beings

Concepts & Ideas

Placebo Effect

Co-author Network

Publications

TOP 3
Marjorie E Gonzalez; Nicole Heffernan; Jess McKenzie; Martin J McKeown; Silke Appel-Cresswell; Katherine Dinelle; A Jon Stoessl; Nasim Vafai; Vesna Sossi
Novel spatial analysis method for PET images using 3D moment invariants: applications to Parkinson's disease.
T Jock Murray; Garth Bray; Morris Freedman; A Jon Stoessl
Neurology in Canada: history of the Canadian Neurological Society.
Matthew D Walker; A Jon Stoessl; Katherine Dinelle; Matthew J Farrer; James E Holden; Rick Kornelsen; Chenoa Mah; Siobhan McCormick; Vesna Sossi
In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jon Stoessl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marjorie E Gonzalez; Nicole Heffernan; Jess McKenzie; Martin J McKeown; Silke Appel-Cresswell; Katherine Dinelle; A Jon Stoessl; Nasim Vafai; Vesna Sossi
Novel spatial analysis method for PET images using 3D moment invariants: applications to Parkinson's disease.
NeuroImage 2013;68():11-21.
2013: T Jock Murray; Garth Bray; Morris Freedman; A Jon Stoessl
Neurology in Canada: history of the Canadian Neurological Society.
Neurology 2013;80(4):406-8.
2013: Matthew D Walker; A Jon Stoessl; Katherine Dinelle; Matthew J Farrer; James E Holden; Rick Kornelsen; Chenoa Mah; Siobhan McCormick; Vesna Sossi
In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2013;33(1):59-66.
2013: Pankaj A Agarwal; A Jon Stoessl
Biomarkers for trials of neuroprotection in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2013;28(1):71-85.
2012: Pankaj Agarwal; Katie Dinelle; Susan Hayflick; Nicole Heffernan; Penelope Hogarth; Renju Kuriakose; Patrick MacLeod; Jessamyn McKenzie; Vesna Sossi; A Jon Stoessl
Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2012;27(13):1698-9.
2012: Oury Monchi; A Jon Stoessl
Imaging neural correlates of mild cognitive impairment in Parkinson's disease.
Lancet neurology 2012;11(8):653-5.
2012: Jana Godau; Anna Hussl; Praween Lolekha; A Jon Stoessl; Klaus Seppi
Neuroimaging: current role in detecting pre-motor Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2012;27(5):634-43.
2012: Min Shi; Vesna Sossi; A Jon Stoessl; Ryan J Uitti; Yu Wang; Zbigniew K Wszolek; Teruo Yokoyama; Cyrus Zabetian; Jan O Aasly; Jeff Armaly; Amy R Furay; Kazuko Hasegawa; James B Leverenz; Jing Zhang
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function.
Neurobiology of aging 2012;33(4):836.e5-7.
2012: A Jon Stoessl
Neuroimaging in the early diagnosis of neurodegenerative disease.
Translational neurodegeneration 2012;1(1):5.
2011: Ramachandiran Nandhagopal; Thomas J Ruth; Michael Schulzer; Vesna Sossi; Jacqueline Cragg; Raul de la Fuente-Fernandez; Lisa Kuramoto; Edwin Mak; Siobhan McCormick; Jess McKenzie; A Jon Stoessl
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.
Brain : a journal of neurology 2011;134(Pt 11):3290-8.
2011: A Jon Stoessl; Wr Wayne Martin; Martin J McKeown; Vesna Sossi
Advances in imaging in Parkinson's disease.
Lancet neurology 2011;10(11):987-1001.
2011: A Puschmann; Ronald F Pfeiffer; A Jon Stoessl; R Kuriakose; J L Lash; J A Searcy; Audrey Strongosky; Carles vilarino-guell; Matthew J Farrer; Owen A Ross; dennis dickson; Zbigniew K Wszolek
A family with Parkinsonism, essential tremor, restless legs syndrome, and depression.
Neurology 2011;76(19):1623-30.
2011: A Jon Stoessl; David J Brooks; David Eidelberg
Milestones in neuroimaging.
Movement disorders : official journal of the Movement Disorder Society 2011;26(6):868-978.
2011: Raúl de La Fuente-Fernández; Michael Schulzer; Lisa Kuramoto; Jacquelyn Cragg; Nandhagopal Ramachandiran; Wing L Au; Edwin Mak; Jess McKenzie; Siobhan McCormick; Vesna Sossi; Thomas J Ruth; Chong S Lee; Donald B Calne; A Jon Stoessl
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Annals of neurology 2011;69(5):803-10.
2011: A Jon Stoessl
Neuroimaging in Parkinson's disease.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2011;8(1):72-81.
2011: A Jon Stoessl
Movement disorders: new insights into Parkinson's disease.
Lancet neurology 2011;10(1):5-7.
2010: A Jon Stoessl
Parkin and Parkinson's disease: differentiated by non-dopaminergic dysfunction?
Experimental neurology 2010;225(1):48-50.
2010: Sarah C Lidstone; Michael Schulzer; Katherine Dinelle; Edwin Mak; Vesna Sossi; Thomas J Ruth; Raul de la Fuente-Fernández; Anthony G Phillips; A Jon Stoessl
Effects of expectation on placebo-induced dopamine release in Parkinson disease.
Archives of general psychiatry 2010;67(8):857-65.
2010: A Jon Stoessl
Continuous dopaminergic therapy in Parkinson disease: time to stride back?
Annals of neurology 2010;68(1):3-5.
2010: R Nandhagopal; Andre R Troiano; Edwin Mak; Michael Schulzer; Mary Catherine Bushnell; A Jon Stoessl
Response to heat pain stimulation in idiopathic Parkinson's disease.
Pain medicine (Malden, Mass.) 2010;11(6):834-40.
2010: Lakshmi N Yatham; Peter F Liddle; Raymond Lam; Athanasios P Zis; A Jon Stoessl; Vesna Sossi; Michael J Adam; Thomas J Ruth
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression.
The British journal of psychiatry : the journal of mental science 2010;196(6):474-9.
2010: A Jon Stoessl
Scans without evidence of dopamine deficiency: the triumph of careful clinical assessment.
Movement disorders : official journal of the Movement Disorder Society 2010;25(5):529-30.
2010: André R Troiano; Michael Schulzer; Raul de la Fuente-Fernandez; Edwin Mak; Jess McKenzie; Vesna Sossi; Siobhan McCormick; Thomas J Ruth; A Jon Stoessl
Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function.
Synapse (New York, N.Y.) 2010;64(2):146-51.
2010: Renju Kuriakose; A Jon Stoessl
Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
Progress in brain research 2010;184():177-92.
2009: A Jon Stoessl
Functional imaging studies of non-motoric manifestations of Parkinson's Disease.
Parkinsonism & related disorders 2009;15 Suppl 3():S13-6.
2009: R Nandhagopal; Lisa Kuramoto; Michael Schulzer; Edwin Mak; J Cragg; Chong S Lee; J McKenzie; S McCormick; Ali Samii; André R Troiano; Thomas J Ruth; Vesna Sossi; Raul de la Fuente-Fernandez; Donald B Calne; A Jon Stoessl
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
Brain : a journal of neurology 2009;132(Pt 11):2970-9.
2009: Raúl de La Fuente-Fernández; Vesna Sossi; Siobhan McCormick; Michael Schulzer; Thomas J Ruth; A Jon Stoessl
Visualizing vesicular dopamine dynamics in Parkinson's disease.
Synapse (New York, N.Y.) 2009;63(8):713-6.
2009: Yulia Golub; Daniela Berg; Donald B Calne; Ronald F Pfeiffer; Ryan Uitti; A Jon Stoessl; Zbigniew K Wszolek; Matthew J Farrer; Jakob C Mueller; Thomas Gasser; Julia Fuchs
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.
Parkinsonism & related disorders 2009;15(7):539-41.
2009: Kazuko Hasegawa; A Jon Stoessl; Teruo Yokoyama; Hisayuki Kowa; Zbigniew K Wszolek; Saburo Yagishita
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.
Parkinsonism & related disorders 2009;15(4):300-6.
2009: Christian Wider; dennis dickson; A Jon Stoessl; Yoshio Tsuboi; Françoise Chapon; Ludwig Gutmann; Bernard Lechevalier; Donald B Calne; David A Personett; Mary Hulihan; Jennifer Kachergus; Rosa Rademakers; Matthew C Baker; Linda L Grantier; O K Sujith; Laura Brown; Susan M Calne; Matthew J Farrer; Zbigniew K Wszolek
Pallidonigral TDP-43 pathology in Perry syndrome.
Parkinsonism & related disorders 2009;15(4):281-6.
2009: André R Troiano; R de la Fuente-Fernandez; Vesna Sossi; Michael Schulzer; Edwin Mak; Thomas J Ruth; A Jon Stoessl
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
Neurology 2009;72(14):1211-6.
2009: Vesna Sossi; Katherine Dinelle; Geoffrey J Topping; James E Holden; Doris Doudet; Michael Schulzer; Thomas J Ruth; A Jon Stoessl; Raul de la Fuente-Fernandez
Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study.
Journal of neurochemistry 2009;109(1):85-92.
2009: C Warren Olanow; Jean-Michel Gracies; Christopher G Goetz; A Jon Stoessl; Thomas Freeman; Jeffrey Kordower; James Godbold; Jose A Obeso
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.
Movement disorders : official journal of the Movement Disorder Society 2009;24(3):336-43.
2009: Matthew J Farrer; Mary Hulihan; Jennifer Kachergus; Justus C Dächsel; A Jon Stoessl; Linda L Grantier; Susan M Calne; Donald B Calne; Bernard Lechevalier; Francoise Chapon; Yoshio Tsuboi; Tatsuo Yamada; Ludwig Gutmann; Bülent Elibol; Kailash P Bhatia; Christian Wider; Carles vilarino-guell; Owen A Ross; Laura A Brown; Monica Castanedes-Casey; dennis dickson; Zbigniew K Wszolek
DCTN1 mutations in Perry syndrome.
Nature genetics 2009;41(2):163-5.
2009: A Jon Stoessl
Radionuclide scanning to diagnose Parkinson disease: is it cost-effective?
Nature clinical practice. Neurology 2009;5(1):10-1.
2008: R Nandhagopal; Edwin Mak; Michael Schulzer; J McKenzie; S McCormick; Vesna Sossi; Thomas J Ruth; A Strongosky; Matthew J Farrer; Zbigniew K Wszolek; A Jon Stoessl
Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study.
Neurology 2008;71(22):1790-5.
2008: William J Marks; Jill L Ostrem; Leonard Verhagen; Philip A Starr; Paul S Larson; Roy A E Bakay; Robin Taylor; Deborah A Cahn-Weiner; A Jon Stoessl; C Warren Olanow; raymond bartus
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.
Lancet neurology 2008;7(5):400-8.
2008: R Nandhagopal; Martin J McKeown; A Jon Stoessl
Functional imaging in Parkinson disease.
Neurology 2008;70(16 Pt 2):1478-88.
2008: W R Wayne Martin; Marguerite Wieler; A Jon Stoessl; Michael Schulzer
Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
Annals of neurology 2008;63(3):388-94.
2007: Vesna Sossi; Raúl de La Fuente-Fernández; Michael Schulzer; André R Troiano; Thomas J Ruth; A Jon Stoessl
Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
Annals of neurology 2007;62(5):468-74.
2007: Sarah C Christine Lidstone; A Jon Stoessl
Understanding the placebo effect: contributions from neuroimaging.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2007;9(4):176-85.
2007: A Jon Stoessl
Gene therapy for Parkinson's disease: early data.
Lancet 2007;369(9579):2056-8.
2007: Ronald B Postuma; Christina Wolfson; Ali H Rajput; A Jon Stoessl; W R Wayne Martin; Oksana Suchowersky; Sylvain Chouinard; Michel Panisset; Mandar S Jog; David A Grimes; Connie Marras; Anthony E Lang
Is there seasonal variation in risk of Parkinson's disease?
Movement disorders : official journal of the Movement Disorder Society 2007;22(8):1097-101.
2007: Steven A Gunzler; A Jon Stoessl; Robert A Egan; Richard G Weleber; Paul Wang; John G Nutt
Joubert syndrome surviving to adulthood associated with a progressive movement disorder.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):262-5.
2007: A Jon Stoessl
Positron emission tomography in premotor Parkinson's disease.
Parkinsonism & related disorders 2007;13 Suppl 3():S421-4.
2006: Rodrigo Mercado; Constantine Constantoyannis; Tomasz Mandat; Ajit Kumar; Michael Schulzer; A Jon Stoessl; Christopher R Honey
Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
Movement disorders : official journal of the Movement Disorder Society 2006;21(9):1457-61.
2006: Zbigniew K Wszolek; Yasuhiko Baba; Ian R A Mackenzie; Ryan Uitti; Audrey Strongosky; Daniel F Broderick; Matthew C Baker; Stacey Melquist; Michael Hutton; Yoshio Tsuboi; J E Allanson; J Carr; A Kumar; Susan M Calne; Judith Miklossy; Patrick L McGeer; Donald B Calne; A Jon Stoessl
Autosomal dominant dystonia-plus with cerebral calcifications.
Neurology 2006;67(4):620-5.
2006: Kaveh M Koochesfahani; Raúl de La Fuente-Fernández; Vesna Sossi; Michael Schulzer; Lakshmi N Yatham; Thomas J Ruth; Stephan Blinder; A Jon Stoessl
Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
Movement disorders : official journal of the Movement Disorder Society 2006;21(7):970-5.
2006: Sian D Spacey; P J Adams; P C P Lam; Luke A Materek; A Jon Stoessl; Terrance P Snutch; Ging-Yuek R Hsiung
Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia.
Neurology 2006;66(10):1588-90.
2006: Anthony E Lang; J William Langston; A Jon Stoessl; Matthew A Brodsky; David J Brooks; Vijay Dhawan; William J Elias; Andres M Lozano; Elena Moro; John G Nutt; Mark Stacy; Dennis Turner; G Frederick Wooten
GDNF in treatment of Parkinson's disease: response to editorial.
Lancet neurology 2006;5(3):200-2.
2006: Anthony E Lang; Steven Gill; Nikunj K Patel; Andres M Lozano; John G Nutt; Richard Penn; David J Brooks; Gary R Hotton; Elena Moro; Peter Heywood; Matthew A Brodsky; Kim J Burchiel; Patrick Kelly; Arif Dalvi; Burton Scott; Mark Stacy; Dennis Turner; V G Frederich Wooten; William J Elias; Edward R Laws; Vijay Dhawan; A Jon Stoessl; James Matcham; Robert J Coffey; Michael Traub
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Annals of neurology 2006;59(3):459-66.
2006: Raúl de La Fuente-Fernández; S Lidstone; A Jon Stoessl
Placebo effect and dopamine release.
Journal of neural transmission. Supplementum 2006;(70):415-8.
2006: Wing Lok Au; John R Adams; André R Troiano; A Jon Stoessl
Neuroimaging in Parkinson's disease.
Journal of neural transmission. Supplementum 2006;(70):241-8.
2005: John R Adams; Hinke van Netten; Michael Schulzer; Edwin Mak; Jessamyn Mckenzie; Audrey Strongosky; Vesna Sossi; Thomas J Ruth; Chong S Lee; Matthew J Farrer; Thomas Gasser; Ryan Uitti; Donald B Calne; Zbigniew K Wszolek; A Jon Stoessl
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
Brain : a journal of neurology 2005;128(Pt 12):2777-85.
2005: Anthony E Lang; Janis M Miyasaki; C Warren Olanow; A Jon Stoessl; Oksana Suchowersky
Progress in clinical neurosciences: a forum on the early management of Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2005;32(3):277-86.
2005: Sarah Furtado; Vesna Sossi; Robert A Hauser; Ali Samii; Michael Schulzer; Colleen B Murphy; Thomas B Freeman; A Jon Stoessl
Positron emission tomography after fetal transplantation in Huntington's disease.
Annals of neurology 2005;58(2):331-7.
2005: Donald B Calne; Michael Schulzer; Edwin Mak; A Jon Stoessl
Treatment for the progression of Parkinson's disease.
Lancet neurology 2005;4(4):206.
2005: Wing Lok Au; John R Adams; André R Troiano; A Jon Stoessl
Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.
Brain research. Molecular brain research 2005;134(1):24-33.
2005: A Jon Stoessl; Patrick L McGeer
Hot spots: can positron emission tomography offer insights into the pathogenesis of PD?
Annals of neurology 2005;57(2):161-2.
2005: B Ravina; David Eidelberg; J Eric Ahlskog; Roger L Albin; David J Brooks; M Carbon; Vijay Dhawan; A Feigin; Stanley Fahn; M Guttman; Katrina Gwinn-Hardy; Henry McFarland; Robert B Innis; R G Katz; Karl Kieburtz; Stephen J Kish; N Lange; J William Langston; Kenneth Marek; L Morin; C Moy; D Murphy; Wolfgang H Oertel; G Oliver; Yuko Y Palesch; W Powers; John P Seibyl; Kapil D Sethi; Clifford W Shults; P Sheehy; A Jon Stoessl; R Holloway
The role of radiotracer imaging in Parkinson disease.
Neurology 2005;64(2):208-15.
2004: J R M Oliveira; Elizabeth Spiteri; Maria-Jesús Sobrido; S Hopfer; J Klepper; T Voit; John Gilbert; Zbigniew K Wszolek; Donald B Calne; A Jon Stoessl; Michael Hutton; B V Manyam; François Boller; M Baquero; Daniel Geschwind
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease).
Neurology 2004;63(11):2165-7.
2004: Chong S Lee; Michael Schulzer; Raúl de La Fuente-Fernández; Edwin Mak; Lisa Kuramoto; Vesna Sossi; Thomas J Ruth; Donald B Calne; A Jon Stoessl
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.
Archives of neurology 2004;61(12):1920-5.
2004: Raúl de La Fuente-Fernández; Vesna Sossi; Zhigao Huang; Sarah Furtado; Jian-Qiang Lu; Donald B Calne; Thomas J Ruth; A Jon Stoessl
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
Brain : a journal of neurology 2004;127(Pt 12):2747-54.
2004: Alexander Zimprich; Saskia Biskup; Petra Leitner; Peter Lichtner; Matthew J Farrer; Sarah J Lincoln; Jennifer Kachergus; Mary Hulihan; Ryan Uitti; Donald B Calne; A Jon Stoessl; Ronald F Pfeiffer; Nadja Patenge; Iria Carballo Carbajal; Peter Vieregge; Friedrich Asmus; Bertram Müller-Myhsok; dennis dickson; Thomas Meitinger; Tim M Strom; Zbigniew K Wszolek; Thomas Gasser
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
Neuron 2004;44(4):601-7.
2004: Constantine Constantoyannis; Ajit Kumar; A Jon Stoessl; Christopher R Honey
Tremor induced by thalamic deep brain stimulation in patients with complex regional facial pain.
Movement disorders : official journal of the Movement Disorder Society 2004;19(8):933-6.
2004: A Jon Stoessl; Raúl de La Fuente-Fernández
Willing oneself better on placebo--effective in its own right.
Lancet 2004;364(9430):227-8.
2004: Raúl de La Fuente-Fernández; Michael Schulzer; A Jon Stoessl
Placebo mechanisms and reward circuitry: clues from Parkinson's disease.
Biological psychiatry 2004;56(2):67-71.
2004: Ajit Kumar; Susan M Calne; Michael Schulzer; Edwin Mak; Zbigniew K Wszolek; Chris van Netten; Joseph K C Tsui; A Jon Stoessl; Donald B Calne
Clustering of Parkinson disease: shared cause or coincidence?
Archives of neurology 2004;61(7):1057-60.
2004: Sarah Furtado; Haydeh Payami; Paul J Lockhart; Melissa Hanson; John G Nutt; Amanda Adam Singleton; Amanda Singleton; Jamel Bower; Ryan J Utti; Thomas D Bird; Raul de la Fuente-Fernandez; Yoshio Tsuboi; Mary L Klimek; Oksana Suchowersky; John Hardy; Donald B Calne; Zbigniew K Wszolek; Matthew J Farrer; Katrina Gwinn-Hardy; A Jon Stoessl
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):622-9.
2004: Zbigniew K Wszolek; Ronald F Pfeiffer; Yoshio Tsuboi; Ryan Uitti; Rodney D McComb; A Jon Stoessl; Audrey Strongosky; Alexander Zimprich; Bertram Müller-Myhsok; Matthew J Farrer; Thomas Gasser; Donald B Calne; dennis dickson
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.
Neurology 2004;62(9):1619-22.
2004: Katja Hedrich; E-M Meyer; Birgitt Schuele; Norman Kock; Patricia de Carvalho Aguiar; Karin Wiegers; J H T M Koelman; Jennifer Garrels; R Dürr; Liu Liu; Eberhard Schwinger; Laurie J Ozelius; B Landwehrmeyer; A Jon Stoessl; Marina A J Tijssen; Christine Klein
Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations.
Neurology 2004;62(7):1229-31.
2004: Raúl de La Fuente-Fernández; Michael Schulzer; Edwin Mak; Donald B Calne; A Jon Stoessl
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
Brain : a journal of neurology 2004;127(Pt 4):888-99.
2004: Raúl de La Fuente-Fernández; A Jon Stoessl
The biochemical bases of the placebo effect.
Science and engineering ethics 2004;10(1):143-50.
2003: Ajit Kumar; Sharanpal Mann; Vesna Sossi; Thomas J Ruth; A Jon Stoessl; Michael Schulzer; Chong S Lee
[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.
Brain : a journal of neurology 2003;126(Pt 12):2648-55.
2003: David J Brooks; Kirk A Frey; Kenneth Marek; David Oakes; D Paty; R Prentice; Clifford W Shults; A Jon Stoessl
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Experimental neurology 2003;184 Suppl 1():S68-79.
2003: A Jon Stoessl
Agonizing over dopaminergic replacement therapy--lessons from animal models of Parkinson's disease.
Experimental neurology 2003;183(1):1-3.
2003: C Warren Olanow; Christopher G Goetz; Jeffrey Kordower; A Jon Stoessl; Vesna Sossi; Mitchell F Brin; Kathleen M Shannon; G Michael Nauert; Daniel P Perl; James Godbold; Thomas B Freeman
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
Annals of neurology 2003;54(3):403-14.
2003: Anders Björklund; Stephen B Dunnett; Patrik Brundin; A Jon Stoessl; Curt R Freed; Robert E Breeze; Marc Levivier; Marc Peschanski; Studer Lorenz; Roger A Barker
Neural transplantation for the treatment of Parkinson's disease.
Lancet neurology 2003;2(7):437-45.
2003: Alan L Whone; Ray L Watts; A Jon Stoessl; Margaret Davis; Sven Reske; Claude Nahmias; Anthony E Lang; Olivier Rascol; Maria J Ribeiro; Philippe Remy; Werner Poewe; Robert A Hauser; David J Brooks
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Annals of neurology 2003;54(1):93-101.
2003: Raúl de La Fuente-Fernández; Sarah Furtado; Mark Guttman; Yoshiaki Furukawa; Chong S Lee; Donald B Calne; Thomas J Ruth; A Jon Stoessl
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
Synapse (New York, N.Y.) 2003;49(1):20-8.
2003: Zhigao Huang; Raúl de La Fuente-Fernández; A Jon Stoessl
Etiology of Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2003;30 Suppl 1():S10-8.
2003: Vesna Sossi; James E Holden; Raul de la Fuente-Fernandez; Thomas J Ruth; A Jon Stoessl
Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2003;23(3):301-9.
2003: Lisa M Inkster; Janice J Eng; Donna L Macintyre; A Jon Stoessl
Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair.
Movement disorders : official journal of the Movement Disorder Society 2003;18(2):157-62.
2003: Raúl de La Fuente-Fernández; Andrew S Lim; Vesna Sossi; Michael J Adam; Thomas J Ruth; Donald B Calne; A Jon Stoessl; Chong S Lee
Age and severity of nigrostriatal damage at onset of Parkinson's disease.
Synapse (New York, N.Y.) 2003;47(2):152-8.
2003: A Jon Stoessl; Chong S Lee; Raul de la Fuente-Fernandez
New concepts and tools in imaging for the study of neurodegenerative disease.
Journal of neural transmission. Supplementum 2003;(65):157-66.
2003: Siobhan E McCormick; A Jon Stoessl
Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
Neuroscience 2003;119(2):547-55.
2003: JM van Kampen; A Jon Stoessl
Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitization to levodopa.
Neuroscience 2003;116(1):307-14.
2003: A Jon Stoessl; Raúl de La Fuente-Fernández
Dopamine receptors in Parkinson's disease: imaging studies.
Advances in neurology 2003;91():65-71.
2002: Raúl de La Fuente-Fernández; A Jon Stoessl
The biochemical bases for reward. Implications for the placebo effect.
Evaluation & the health professions 2002;25(4):387-98.
2002: Sarah Furtado; Matthew J Farrer; Yoshio Tsuboi; M L Klimek; Raúl de La Fuente-Fernández; Jennifer Hussey; Paul Lockhart; Donald B Calne; Oksana Suchowersky; A Jon Stoessl; Zbigniew K Wszolek
SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.
Neurology 2002;59(10):1625-7.
2002: Raúl de La Fuente-Fernández; Anthony G Phillips; Mariangela Zamburlini; Vesna Sossi; Donald B Calne; Thomas J Ruth; A Jon Stoessl
Dopamine release in human ventral striatum and expectation of reward.
Behavioural brain research 2002;136(2):359-63.
2002: Henry G Dunn; A Jon Stoessl; Helena H Ho; Patrick M MacLeod; Kenneth J Poskitt; Doris J Doudet; Michael Schulzer; Derek Blackstock; Teresa Dobko; Ben Koop; Giovana V de Amorim
Rett syndrome: investigation of nine patients, including PET scan.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2002;29(4):345-57.
2002: Lakshmi N Yatham; Peter F Liddle; Raymond Lam; I-Shin Shiah; Carol Lane; A Jon Stoessl; Vesna Sossi; Thomas J Ruth
PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania.
The American journal of psychiatry 2002;159(10):1718-23.
2002: A Jon Stoessl
"Stiff in the closet"--who provides care for Parkinsonian patients?
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2002;29(3):203-4.
2002: Raúl de La Fuente-Fernández; A Jon Stoessl
Parkinson's disease: imaging update.
Current opinion in neurology 2002;15(4):477-82.
2002: Pramod Kumar Pal; Joanne Leung; Katya Hedrich; Ali Samii; Abraham Lieberman; Paul A Nausieda; Donald B Calne; Xandra O Breakefield; Christine Klein; A Jon Stoessl
[18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2002;17(4):789-94.
2002: Robert A Hauser; Paul R Sandberg; Thomas B Freeman; A Jon Stoessl
Bilateral human fetal striatal transplantation in Huntington's disease.
Neurology 2002;58(11):1704; author reply 1704.
2002: Raúl de La Fuente-Fernández; Michael Schulzer; A Jon Stoessl
The placebo effect in neurological disorders.
Lancet neurology 2002;1(2):85-91.
2002: Raúl de La Fuente-Fernández; A Jon Stoessl
The placebo effect in Parkinson's disease.
Trends in neurosciences 2002;25(6):302-6.
2002: Robert A Hauser; Sarah Furtado; CR Cimino; H Delgado; S Eichler; S Schwartz; D Scott; G Michael Nauert; E Soety; Vesna Sossi; D A Holt; Paul Sanberg; A Jon Stoessl; Thomas B Freeman
Bilateral human fetal striatal transplantation in Huntington's disease.
Neurology 2002;58(5):687-95.
2002: Vesna Sossi; Raúl de La Fuente-Fernández; James E Holden; Doris J Doudet; Jess McKenzie; A Jon Stoessl; Thomas J Ruth
Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2002;22(2):232-9.
2002: Siobhan E McCormick; A Jon Stoessl
Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia.
Neuroscience 2002;112(4):851-9.
2002: J Q Lu; A Jon Stoessl
Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats.
Neuroscience 2002;112(2):261-6.
2001: Raúl de La Fuente-Fernández; Andrew S Lim; Vesna Sossi; James E Holden; Donald B Calne; Thomas J Ruth; A Jon Stoessl
Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2001;21(10):1151-9.
2001: A Jon Stoessl
Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it?
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):804-6.
2001: Pramod Kumar Pal; Zbigniew K Wszolek; Ryan Uitti; K Markopoulou; Susan M Calne; A Jon Stoessl; Donald B Calne
Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes.
Parkinsonism & related disorders 2001;8(1):51-6.
2001: Raúl de La Fuente-Fernández; Thomas J Ruth; Vesna Sossi; Michael Schulzer; Donald B Calne; A Jon Stoessl
Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
Science (New York, N.Y.) 2001;293(5532):1164-6.
2001: Raúl de La Fuente-Fernández; J Q Lu; Vesna Sossi; Salma Jivan; Michael Schulzer; James E Holden; Chong S Lee; Thomas J Ruth; Donald B Calne; A Jon Stoessl
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
Annals of neurology 2001;49(3):298-303.
2001: A Jon Stoessl
Neurochemical and neuroreceptor imaging with PET in Parkinson's disease.
Advances in neurology 2001;86():215-23.
2000: JM van Kampen; Edith G McGeer; A Jon Stoessl
Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
Synapse (New York, N.Y.) 2000;37(3):171-8.
2000: Raúl de La Fuente-Fernández; A Kishore; Donald B Calne; Thomas J Ruth; A Jon Stoessl
Nigrostriatal dopamine system and motor lateralization.
Behavioural brain research 2000;112(1-2):63-8.
2000: Vesna Sossi; James E Holden; G Chan; M Krzywinski; A Jon Stoessl; Thomas J Ruth
Analysis of four dopaminergic tracers kinetics using two different tissue input function methods.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2000;20(4):653-60.
2000: Chong S Lee; Ali Samii; Vesna Sossi; Thomas J Ruth; Michael Schulzer; James E Holden; J Wudel; Pramod Kumar Pal; Raul de la Fuente-Fernandez; Donald B Calne; A Jon Stoessl
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
Annals of neurology 2000;47(4):493-503.
2000: JM van Kampen; A Jon Stoessl
Dopamine D(1A) receptor function in a rodent model of tardive dyskinesia.
Neuroscience 2000;101(3):629-35.
2000: JM van Kampen; A Jon Stoessl
Effects of oligonucleotide antisense to dopamine D(1A) receptor messenger RNA in a rodent model of levodopa-induced dyskinesia.
Neuroscience 2000;98(1):61-7.
2000: Raúl de La Fuente-Fernández; Pramod Kumar Pal; FJ Vingerhoets; A Kishore; Michael Schulzer; Edwin Mak; Thomas J Ruth; BJ Snow; Donald B Calne; A Jon Stoessl
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(1):49-57.
1999: Ali Samii; K Markopoulou; Zbigniew K Wszolek; Vesna Sossi; Teresa Dobko; Edwin Mak; Donald B Calne; A Jon Stoessl
PET studies of parkinsonism associated with mutation in the alpha-synuclein gene.
Neurology 1999;53(9):2097-102.
1999: A Jon Stoessl
Etiology of Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1999;26 Suppl 2():S5-12.
1999: A Jon Stoessl; J Rivest
Differential diagnosis of parkinsonism.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1999;26 Suppl 2():S1-4.
1999: Christopher R Honey; A Jon Stoessl; Joseph K C Tsui; Michael Schulzer; Donald B Calne
Unilateral pallidotomy for reduction of parkinsonian pain.
Journal of neurosurgery 1999;91(2):198-201.
1999: GL Chan; James E Holden; A Jon Stoessl; Ali Samii; Doris J Doudet; Teresa Dobko; KS Morrison; M Adam; Michael Schulzer; Donald B Calne; Thomas J Ruth
Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(2):283-9.
1998: Y Wang; GL Chan; James E Holden; Teresa Dobko; Edwin Mak; Michael Schulzer; J M Huser; BJ Snow; Thomas J Ruth; Donald B Calne; A Jon Stoessl
Age-dependent decline of dopamine D1 receptors in human brain: a PET study.
Synapse (New York, N.Y.) 1998;30(1):56-61.
1998: A Jon Stoessl; Thomas J Ruth
Neuroreceptor imaging: new developments in PET and SPECT imaging of neuroreceptor binding (including dopamine transporters, vesicle transporters and post synaptic receptor sites).
Current opinion in neurology 1998;11(4):327-33.
1998: Raúl de La Fuente-Fernández; A Kishore; BJ Snow; Michael Schulzer; Chong S Lee; Thomas J Ruth; A Jon Stoessl
Effect of age on caudate dopaminergic function in idiopathic Parkinsonism.
Parkinsonism & related disorders 1998;4(1):1-5.
1998: GL Chan; James E Holden; A Jon Stoessl; Doris J Doudet; Y Wang; Teresa Dobko; KS Morrison; J M Huser; C English; B Legg; Michael Schulzer; Donald B Calne; Thomas J Ruth
Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(5):792-7.
1998: A Kishore; T G Nygaard; Raul de la Fuente-Fernandez; A B Naini; Michael Schulzer; Edwin Mak; Thomas J Ruth; Donald B Calne; BJ Snow; A Jon Stoessl
Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
Neurology 1998;50(4):1028-32.
1997: JM van Kampen; A Jon Stoessl
The effects of CCK-4 on dopamine D1 agonist-induced grooming are blocked by a CCK(A) receptor antagonist: evidence for a novel CCK receptor subtype?
Neuropharmacology 1997;36(11-12):1679-88.
1997: Nagalingam Rajakumar; Lisanne G Laurier; Hyman B Niznik; A Jon Stoessl
Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.
Synapse (New York, N.Y.) 1997;26(3):199-208.
1997: Y Wang; IM Turnbull; Susan M Calne; A Jon Stoessl; Donald B Calne
Pallidotomy for tardive dyskinesia.
Lancet 1997;349(9054):777-8.
1997: D D Newman; Nagalingam Rajakumar; BA Flumerfelt; A Jon Stoessl
A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease.
Neuroreport 1997;8(3):669-72.
1997: Peter C Williamson; Ashok K Malla; Leonardo Cortese; A Jon Stoessl; Dick J Drost; Jeffrey Stanley
Phosphorus 31 magnetic resonance spectroscopy in patients with Huntington disease.
Archives of general psychiatry 1997;54(2):186-8.
1997: Nagalingam Rajakumar; Walter J Rushlow; B Rajakumar; Christian C G Naus; A Jon Stoessl; BA Flumerfelt
Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum.
Neuroscience 1997;76(4):1173-85.
1997: A Jon Stoessl; Kathi A James; B J Napier
The neurotensin antagonist SR 48692 fails to modify the behavioural responses to a dopamine D1 receptor agonist in the rat.
Neuropharmacology 1997;36(1):93-9.
1996: A Jon Stoessl; Nagalingam Rajakumar
Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the rat.
Synapse (New York, N.Y.) 1996;24(3):256-61.
1996: A Jon Stoessl
Which dopamine receptor(s) do we need for motor function? Lessons from gene targeting and translational blockade.
Parkinsonism & related disorders 1996;2(4):167-75.
1996: A Jon Stoessl
Effects of ethanol in a putative rodent model of tardive dyskinesia.
Pharmacology, biochemistry, and behavior 1996;54(3):541-6.
1996: J Van Kampen; H Frydryszak; A Jon Stoessl
Behavioural evidence for cholecystokinin-dopamine D1 receptor interactions in the rat.
European journal of pharmacology 1996;298(1):7-15.
1995: A Jon Stoessl; M Brackstone; Nagalingam Rajakumar; Candace J Gibson
Pharmacological characterization of grooming induced by a selective NK-1 tachykinin receptor agonist.
Brain research 1995;700(1-2):115-20.
1995: Seemant Chaturvedi; T Ostbye; A Jon Stoessl; H Merskey; vladimir hachinski
Environmental exposures in elderly Canadians with Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1995;22(3):232-4.
1995: A Jon Stoessl
Effects of neurotensin in a rodent model of tardive dyskinesia.
Neuropharmacology 1995;34(4):457-62.
1994: A Jon Stoessl
Dopamine D1 receptor agonist-induced grooming is blocked by the opioid receptor antagonist naloxone.
European journal of pharmacology 1994;259(3):301-3.
1994: A Jon Stoessl
Localization of striatal and nigral tachykinin receptors in the rat.
Brain research 1994;646(1):13-8.
1993: A Jon Stoessl; E Polanski; H Frydryszak
Effects of ageing on tachykinin function in the basal ganglia.
Brain research 1993;632(1-2):21-8.
1993: A Jon Stoessl; E Polanski; H Frydryszak
The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia.
Movement disorders : official journal of the Movement Disorder Society 1993;8(4):445-52.
1993: A Jon Stoessl; E Polanski
Neuroleptic-induced chewing movements in the rat are suppressed by peripherally but not centrally administered CCK and abolished by bilateral subdiaphragmatic vagotomy.
Neuropharmacology 1993;32(6):555-60.
1992: A Jon Stoessl
Prevention and management of late stage complications in Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1992;19(1 Suppl):113-6.
1992: W R Wayne Martin; C Clark; W Ammann; A Jon Stoessl; W Shtybel; Michael R Hayden
Cortical glucose metabolism in Huntington's disease.
Neurology 1992;42(1):223-9.
1991: A Jon Stoessl; E Szczutkowski; B Glenn; I Watson
Behavioural effects of selective tachykinin agonists in midbrain dopamine regions.
Brain research 1991;565(2):254-62.
1991: A Jon Stoessl; E Szczutkowski
Neurotensin and neurotensin analogues modify the effects of chronic neuroleptic administration in the rat.
Brain research 1991;558(2):289-95.
1990: A Jon Stoessl; D R Hill
Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide.
Brain research 1990;534(1-2):1-7.
1990: A Jon Stoessl; C T Dourish; S D Iversen
Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT.
Brain research 1990;517(1-2):111-6.
1989: A Jon Stoessl; M T Martin-Iverson; T M Barth; C T Dourish; S D Iversen
Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy.
Brain research 1989;495(1):20-30.
1989: A Jon Stoessl; C T Dourish; S D Iversen
Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.
Psychopharmacology 1989;98(3):372-9.
1988: A Jon Stoessl; C T Dourish; S D Iversen
The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
British journal of pharmacology 1988;94(2):285-7.
1988: W R Wayne Martin; A Jon Stoessl; M Palmer; M J Adam; Thomas J Ruth; J R Grierson; B D Pate; Donald B Calne
PET scanning in dystonia.
Advances in neurology 1988;50():223-9.
1988: A Jon Stoessl; C T Dourish; S D Iversen
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
Psychopharmacology 1988;95(4):502-6.
1987: A Jon Stoessl; C T Dourish; S C Young; B J Williams; S D Iversen; L L Iversen
Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse.
Neuroscience letters 1987;80(3):321-6.
1987: Michael R Hayden; J Hewitt; A Jon Stoessl; C Clark; W Ammann; W R Wayne Martin
The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease.
Neurology 1987;37(9):1441-7.
1987: C Clark; M Hayden; S Hollenberg; D Li; A Jon Stoessl
Controlling for cerebral atrophy in positron emission tomography data.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1987;7(4):510-2.
1987: R D Fross; W R Wayne Martin; D Li; A Jon Stoessl; M J Adam; Thomas J Ruth; B D Pate; K Burton; Donald B Calne
Lesions of the putamen: their relevance to dystonia.
Neurology 1987;37(7):1125-9.
1987: A Jon Stoessl; C T Dourish; S D Iversen
Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.
Psychopharmacology 1987;93(3):336-42.
1987: W R Wayne Martin; A Jon Stoessl; M J Adam; W Ammann; M Bergstrom; R Harrop; A Laihinen; J G Rogers; Thomas J Ruth; C I Sayre
Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
Advances in neurology 1987;45():95-8.
1987: Donald B Calne; A Jon Stoessl
Transmitter receptor alterations in Parkinson's disease.
Advances in neurology 1987;45():45-9.
1986: C M Clark; Michael R Hayden; A Jon Stoessl; W R Martin
Regression model for predicting dissociations of regional cerebral glucose metabolism in individuals at risk for Huntington's disease.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1986;6(6):756-62.
1986: J K Tsui; Andrew Eisen; A Jon Stoessl; S Calne; Donald B Calne
Double-blind study of botulinum toxin in spasmodic torticollis.
Lancet 1986;2(8501):245-7.
1986: C M Clark; A Jon Stoessl
Glucose use correlations: a matter of inference.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1986;6(4):511-2.
1986: Michael R Hayden; W R Wayne Martin; A Jon Stoessl; C Clark; S Hollenberg; M J Adam; W Ammann; R Harrop; J Rogers; Thomas J Ruth
Positron emission tomography in the early diagnosis of Huntington's disease.
Neurology 1986;36(7):888-94.
1986: A Jon Stoessl; W R Wayne Martin; C Clark; M J Adam; W Ammann; J H Beckman; M Bergstrom; R Harrop; J G Rogers; Thomas J Ruth
PET studies of cerebral glucose metabolism in idiopathic torticollis.
Neurology 1986;36(5):653-7.
1986: Donald B Calne; A Jon Stoessl
Early parkinsonism.
Clinical neuropharmacology 1986;9 Suppl 2():S3-8.
1986: Oksana Suchowersky; Michael R Hayden; W R Wayne Martin; A Jon Stoessl; A M Hildebrand; B D Pate
Cerebral metabolism of glucose in benign hereditary chorea.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):33-44.
1985: A Jon Stoessl; Edwin Mak; Donald B Calne
(+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonism.
Lancet 1985;2(8468):1330-1.
1985: A Jon Stoessl; A F Hahn; D Malott; D T Jones; M D Silver
Nemaline myopathy with associated cardiomyopathy. Report of clinical and detailed autopsy findings.
Archives of neurology 1985;42(11):1084-6.
1985: Donald B Calne; J William Langston; W R Wayne Martin; A Jon Stoessl; Thomas J Ruth; M J Adam; B D Pate; M Schulzer
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.
Nature 1985;317(6034):246-8.
1985: A Jon Stoessl; G B Young; T E Feasby
Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergics.
Stroke; a journal of cerebral circulation 1985;16(4):734-6.
1977: M Ali; Jiri Zamecnik; A L Cerskus; A Jon Stoessl; W H Barnett; J W McDonald
Synthesis of thromboxane B2 and prostaglandins by bovine gastric mucosal microsomes.
Prostaglandins 1977;14(5):819-27.